Trending: Grifols Founding Family, Brookfield Eye Takeover Bid for Spanish Drugmaker
1023 GMT - Grifols is among the most mentioned companies in news items in Europe over the past 12 hours, according to Factiva data. Trading of Grifols shares were suspended on Monday, after Grifols confirmed that the Spanish pharmaceutical company is considering delisting from the stock market, following a media report by Spanish newspaper CincoDias on Sunday. This potential move involves a joint deal with Canadian investment firm Brookfield and Grifols' founding family. The company's share price has dropped 75% since its 2020 peak, and insiders currently control about 31% of the company, according to FactSet data. Grifols has a current market capitalization of EUR5.5 billion. Dow Jones & Co. owns Factiva. (helena.smolak@wsj.com)
(END) Dow Jones Newswires
July 08, 2024 06:40 ET (10:40 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks
United States